Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Keith A. Cockerill
Observed names:
Keith A Cockerill,
Keith Cockerill
Institution:
Amgen (United States)
Observed institutions:
Amgen (United States),
University of California, Santa Barbara,
UNSW Sydney,
St George Hospital,
La Jolla Pharmaceutical (United States)
OpenAlex ID:
A5011148367
Anti–β2‐glycoprotein I antibodies in complex with β2‐glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib‐IX‐V
2006
·
Tong Shi
, Bill Giannakopoulos
, et al.
·
Arthritis & Rheumatism
·
169
Use of Single Point Mutations in Domain I of β2-Glycoprotein I to Determine Fine Antigenic Specificity of Antiphospholipid Autoantibodies
2002
·
G Michael Iverson
, Stephen Reddel
, et al.
·
The Journal of Immunology
·
146
PDF
β 2 -Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: Loss of inhibition by clipped β 2 -glycoprotein I
2004
·
Tong Shi
, G. Michael Iverson
, et al.
·
Proceedings of the National Academy of Sciences
·
98
Isolation of a family of Drosophila POU domain genes expressed in early development
1991
·
Andrew N. Billin
, Keith A. Cockerill
, et al.
·
Mechanisms of Development
·
88
The Orientation of β2GPI on the Plate is Important for the Binding of Anti-β2GPI Autoantibodies by ELISA
2002
·
G.Michael Iverson
, Eiji Matsuura
, et al.
·
Journal of Autoimmunity
·
36
Domain V of β2-Glycoprotein I Binds Factor XI/XIa and Is Cleaved at Lys317-Thr318
2004
·
Tong Shi
, Bill Giannakopoulos
, et al.
·
Journal of Biological Chemistry
·
32
Regulation of expression domains and effects of ectopic expression reveal gap gene-like properties of the linked pdm genes of Drosophila
1993
·
Keith A. Cockerill
, Andrew N. Billin
, et al.
·
Mechanisms of Development
·
23
Synthesis of LJP 993, a Multivalent Conjugate of the N-Terminal Domain of β2GPI and Suppression of an Anti-β2GPI Immune Response
2001
·
David S. Jones
, Keith A. Cockerill
, et al.
·
Bioconjugate Chemistry
·
19
Therapeutic Potential of Toleragens in the Management of Antiphospholipid Syndrome
2004
·
Keith A Cockerill
, G Michael Iverson
, et al.
·
BioDrugs
·
18
Multivalent Poly(ethylene glycol)-Containing Conjugates for In Vivo Antibody Suppression
2003
·
David S. Jones
, Michael J. Branks
, et al.
·
Bioconjugate Chemistry
·
12
Examining Manufacturing Readiness for Breakthrough Drug Development
2015
·
Earl Dye
, Annie Sturgess
, et al.
·
AAPS PharmSciTech
·
11
PDF
In vivo characterization of bioconjugate B cell toleragens with specificity for autoantibodies in antiphospholipid syndrome
2003
·
Keith A. Cockerill
, Eric Smith
, et al.
·
International Immunopharmacology
·
8
Advances in understanding what we measure when detecting anticardiolipin autoantibodies
2004
·
G.Michael Iverson
, Edward J. Victoria
, et al.
·
Clinica Chimica Acta
·
6
Detection and characterization of B cell epitopes on β2-glycoprotein I
2004
·
Keith A Cockerill
, Matthew D Linnik
, et al.
·
Clinical Immunology
·
5
Show more works
View as search
Works count:
14
Citation count:
671
H-index:
11
I10-index:
11
Year
Topic
Type